TECX
NASD Tectonic Therapeutic Inc$0.0000 ↓ -22.3500 (-100.00%) Trading Down from the previous close of $22.3500
- YTD change
- N/A
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-7.61 (-25.40%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $61.0700
- TECX is down 100% since the beginning of the year
- TECX is down 100% over the past 12 months
- TECX is down 100% over the past 1 month
- 25% of all TECX investors are betting against TECX
TECX reads poor: the 12-month move is +38.9%.
- Previous minute
- N/A
- Last hour
- N/A
- Last 5 days
- N/A
- vs 8-day SMA
- N/A
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
